IRIC - Institute for Research in Immunology and Cancer

Marc Therrien elected member of the Canadian Academy of Health Sciences

Marc Therrien, Principal Investigator in the Intracellular Signalling Research Unit and Chief Executive Officer of IRIC, as well as Full Professor in the Department of Pathology and Cell Biology at the Faculty of Medicine of the Université de Montréal, joins the Canadian Academy of Health Sciences (CAHS) as a new member. A total of 47 new members have been elected to the CAHS for the year 2025.

IRIC highlights the scientific knowledge of the next generation!

The 7th edition of IRIC’s 2025 Summer Interns’ Scientific Day was held on Thursday, August 7.

Fall 2025 Scientific Conferences

September 8—December 8, 2025

IRIC presents the 39th edition of its Fall 2025 Scientific Conferences.

Behind-the-scenes work brought to light: CIHR award for investigators Gregory Emery and David Knapp

Gregory Emery and David Knapp, directors of the IRIC Vesicular Trafficking and Cell Signalling Research Unit and Cellular Engineering Research Unit, respectively, have both received a special mention for outstanding contribution from the Canadian Institutes of Health Research (CIHR) College of Reviewers. In addition, Gregory Emery was recognized for his outstanding evaluation services during three or more consecutive project grant competitions, a distinction awarded to only 1% of evaluators nationwide. David Knapp received three citations for outstanding contribution. This recognition reflects the remarkable quality of their evaluation work and their constructive participation in committee discussions.

Unmutated tumor antigens: exploitable targets for immunotherapy

The team headed by Claude Perreault, Director of IRIC’s Immunobiology Research Unit, has identified novel tumor antigens that could lead to the development of vaccines for the treatment of two cancers: melanoma and non-small cell lung cancer. To achieve this, the team led by PhD student Anca Apavaloaei has adopted an unbiased approach that examines all genetic material, including DNA described as “junk” because it is not coding for any known protein. The work, the fruit of collaborations with the Epitopea company, McGill University, the University of Liège and the University of Lausanne, has been published in the journal Nature Cancer.

Running: a mirror of life. Testimony of Sasmita Tripathy, Assistant Director of IRIC’s Drug Discovery Unit

Sasmita Tripathy has been a runner for many years, a sport she loves for both her physical and psychological well-being. Through her testimony, she shows us how all spheres of her life are interrelated; a touching reflection that highlights her determination, her kindness and her will to change things, both in the laboratory and in her personal life. IRIC is proud to present this inspiring personality.